Abstract
Sjogren’s syndrome is a systemic autoimmune condition centred around salivary gland dysfunction and atrophy. There are a plethora of antibodies that mark the decline of the salivary glands, most of which relate to apoptopic mediated destruction of acinar cells. The best known of these autoantibodies, anti-Ro and anti-La form part of the diagnostic criteria for the condition. An emerging viewpoint in recent years is that glandular dysfunction precedes rather than follows glandular atrophy and attention has shifted to the interface between the immune system and the secretory process. An autoantibody against the muscarinic type 3 acetylcholine receptor occupies precisely this position because it inhibits the acetylcholine receptor which controls salivary and lacrimal fluid secretion. The consequence of identifying an autoantibody that can cause rather than simply reflect the disease process are manifold and could have a huge impact on development of therapeutic treatments. Furthermore, a “functional” autoantibody directed against an important component of the autonomic nervous system could also account for some of the extraglandular features of Sjogren’s syndrome.
Keywords: Autoantibody, lacrimal, muscarinic type 3 receptor, salivary, sjogren’s syndrome, xeropthalmia, xerostomia, systemic autoimmune, salivary gland dysfunction, plethora, atrophy, immune system, secretory process, lacrimal fluid secretion, autonomic nervous system.
Current Pharmaceutical Biotechnology
Title:Autoantibodies and Sjogren’s Syndrome: A Physiologist’s Perspective
Volume: 13 Issue: 10
Author(s): Peter M. Smith and Luke J. Dawson
Affiliation:
Keywords: Autoantibody, lacrimal, muscarinic type 3 receptor, salivary, sjogren’s syndrome, xeropthalmia, xerostomia, systemic autoimmune, salivary gland dysfunction, plethora, atrophy, immune system, secretory process, lacrimal fluid secretion, autonomic nervous system.
Abstract: Sjogren’s syndrome is a systemic autoimmune condition centred around salivary gland dysfunction and atrophy. There are a plethora of antibodies that mark the decline of the salivary glands, most of which relate to apoptopic mediated destruction of acinar cells. The best known of these autoantibodies, anti-Ro and anti-La form part of the diagnostic criteria for the condition. An emerging viewpoint in recent years is that glandular dysfunction precedes rather than follows glandular atrophy and attention has shifted to the interface between the immune system and the secretory process. An autoantibody against the muscarinic type 3 acetylcholine receptor occupies precisely this position because it inhibits the acetylcholine receptor which controls salivary and lacrimal fluid secretion. The consequence of identifying an autoantibody that can cause rather than simply reflect the disease process are manifold and could have a huge impact on development of therapeutic treatments. Furthermore, a “functional” autoantibody directed against an important component of the autonomic nervous system could also account for some of the extraglandular features of Sjogren’s syndrome.
Export Options
About this article
Cite this article as:
M. Smith Peter and J. Dawson Luke, Autoantibodies and Sjogren’s Syndrome: A Physiologist’s Perspective, Current Pharmaceutical Biotechnology 2012; 13 (10) . https://dx.doi.org/10.2174/138920112802273218
DOI https://dx.doi.org/10.2174/138920112802273218 |
Print ISSN 1389-2010 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4316 |
Call for Papers in Thematic Issues
Artificial Intelligence in Bioinformatics
Bioinformatics is an interdisciplinary field that analyzes and explores biological data. This field combines biology and information system. Artificial Intelligence (AI) has attracted great attention as it tries to replicate human intelligence. It has become common technology for analyzing and solving complex data and problems and encompasses sub-fields of machine ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Dietary Fatty Acids in Metabolic Syndrome, Diabetes and Cardiovascular Diseases
Current Diabetes Reviews Targeting JAK3 Tyrosine Kinase-Linked Signal Transduction Pathways with Rationally-Designed Inhibitors
Anti-Cancer Agents in Medicinal Chemistry Advanced Approaches of Bioactive Peptide Molecules and Protein Drug Delivery Systems
Current Pharmaceutical Design Radioprotective Gene Therapy
Current Gene Therapy Inulin as a Delivery Vehicle for Targeting Colon-Specific Cancer
Current Drug Delivery Skin Cancers in Elderly Patients
Anti-Cancer Agents in Medicinal Chemistry Breaking the DNA Damage Response via Serine/Threonine Kinase Inhibitors to Improve Cancer Treatment
Current Medicinal Chemistry Photosensitization of Biomolecules by Phenothiazine Derivatives
Current Drug Targets The Development of MetAP-2 Inhibitors in Cancer Treatment
Current Medicinal Chemistry p53 Gene Family: Structural, Functional and Evolutionary Features
Current Genomics Quantification of Intracellular Proteins and Monitoring Therapy Using Flow Cytometry
Current Drug Targets Randomised Trials of Graft Versus Host Disease Prophylaxis in Haemopoietic Stem Cell Transplantation
Reviews on Recent Clinical Trials STING Activation and its Application in Immuno-Oncology
Current Topics in Medicinal Chemistry Radionuclide Antibody-Conjugates, a Targeted Therapy Towards Cancer
Current Radiopharmaceuticals Glucagon-Like Peptide-1-Mediated Modulation of Inflammatory Pathways in the Diabetic Brain: Relevance to Alzheimer’s Disease
Current Alzheimer Research Molecular Mechanisms Regulating Matrix Metalloproteinases
Current Topics in Medicinal Chemistry Biological Activity and Delivery of Peptide Nucleic Acids (PNA)-DNA Chimeras for Transcription Factor Decoy (TFD) Pharmacotherapy
Current Medicinal Chemistry Prevalence of Pre-Existing Risk Factors for Adverse Events Associated with Atypical Antipsychotics Among Commercially Insured and Medicaid Insured Patients Newly Initiating Atypical Antipsychotics
Current Drug Safety Polymer Drug Conjugates: Recent Advancements in Various Diseases
Current Pharmaceutical Design Pharmacological Effects of Biotin in Animals
Mini-Reviews in Medicinal Chemistry